PRNewsWire
08 Nov 2025, 06:56 UTC · 45w ago
Verdict
Headline takes no side. We score CYTK −1.00 — strongly bearish.
−1.00strongly bearish
More negative than 95% of ticker scores this week
Which stocks this story touches
More negative than 95% of ticker scores this week
The company is facing a federal securities class action lawsuit alleging misleading statements about FDA approval timelines.
More negative than 86% of ticker scores this week
The company is mentioned as being under investigation for potential claims in a securities class action.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 1 mover · tap to explore
More negative than 86% of ticker scores this week
The company is mentioned as being under investigation for potential claims in a securities class action.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
GlobeNewsWire
6h ago
+8.3%
Price is moving against the score
$65.14 vs $60.16 close before publication (Nov 7) · not market-adjusted
CYTK chart →
